NSEBSECOMMODITYNASDAQNYSEFOREXINDICESAMEXUSA More...

ACAD announcements Acadia Pharmaceuticals Inc. announcements and dividends declared NASDAQ

Acadia Pharmaceuticals Inc. Complete list of announcements declared & dividend announcements by Acadia Pharmaceuticals Inc. ACAD

Acadia Pharmaceuticals Inc. ACAD listed on NASDAQ and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Acadia Pharmaceuticals Inc. ACAD

Acadia Pharmaceuticals Reaches Analyst Target Price
In recent trading, shares of Acadia Pharmaceuticals Inc (Symbol: ACAD) have crossed above the average analyst 12-month target price of .06, changing hands for .34/share. When a stock reaches the target an analyst has set, the analyst logically has t
Announcement as on 22 August 2023

Cantor Fitzgerald Maintains Acadia Pharmaceuticals (ACAD) Overweight Recommendation
Fintel reports that on July 17, 2023, Cantor Fitzgerald maintained coverage of Acadia Pharmaceuticals (NASDAQ:ACAD) with a Overweight recommendation. Analyst Price Forecast Suggests 24.48% Downside
Announcement as on 18 July 2023

: Acadia Pharmaceuticals stock rockets 30% following expanded drug rights
Acadia Pharmaceuticals Inc. ACAD shares rallied in the extended session Thursday after the drug maker said it expanded its rights to a treatment for a rare neurological disorder. Acadia shares rallied as much as 30% after hours, following a 0.2% decline to
Announcement as on 13 July 2023

Acadia Pharmaceuticals Reaches Analyst Target Price
In recent trading, shares of Acadia Pharmaceuticals Inc (Symbol: ACAD) have crossed above the average analyst 12-month target price of .47, changing hands for .48/share. When a stock reaches the target an analyst has set, the analyst logically has t
Announcement as on 20 January 2023

Acadia Pharmaceuticals stock halted for FDA panel to review treatment for hallucinations stemming from Alzheimer's disease psychosis
Acadia Pharmaceuticals Inc. said Friday its stock will be halted from trading Friday as a U.S. Food and Drug Administration panel meets virtually to discuss a new drug application for a treatment for hallucinations and delusions associated with Alzheimer'
Announcement as on 17 June 2022

Announcements by Acadia Pharmaceuticals Inc. first page | Next page |

ACAD Acadia Pharmaceuticals Inc. current price & indicator signals